148 related articles for article (PubMed ID: 35152432)
1. Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management.
MacDougall C; Canonica T; Keh C; P Phan BA; Louie J
Pharmacotherapy; 2022 Apr; 42(4):343-361. PubMed ID: 35152432
[TBL] [Abstract][Full Text] [Related]
2. Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.
Simmons KB; Haddad LB; Nanda K; Curtis KM
BJOG; 2018 Jun; 125(7):804-811. PubMed ID: 29130574
[TBL] [Abstract][Full Text] [Related]
3. Update on rifampin, rifabutin, and rifapentine drug interactions.
Baciewicz AM; Chrisman CR; Finch CK; Self TH
Curr Med Res Opin; 2013 Jan; 29(1):1-12. PubMed ID: 23136913
[TBL] [Abstract][Full Text] [Related]
4. Effects of Rifamycin Coadministration on Bedaquiline Desmethylation in Healthy Adult Volunteers.
Healan AM; Salata RA; Griffiss JM; Proskin HM; O'Riordan MA; Gray WA; Blumer JL
Clin Pharmacol Drug Dev; 2019 May; 8(4):436-442. PubMed ID: 30500116
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of concomitant rifamycin and opioid therapy: A systematic review.
Kinney EM; Vijapurapu S; Covvey JR; Nemecek BD
Pharmacotherapy; 2021 May; 41(5):479-489. PubMed ID: 33748959
[TBL] [Abstract][Full Text] [Related]
6. Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.
Healan AM; Griffiss JM; Proskin HM; O'Riordan MA; Gray WA; Salata RA; Blumer JL
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061739
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
Shantsila E; Lip GY
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
[TBL] [Abstract][Full Text] [Related]
8. Effect of rifampin and rifabutin on the pharmacokinetics of lersivirine and effect of lersivirine on the pharmacokinetics of rifabutin and 25-O-desacetyl-rifabutin in healthy subjects.
Vourvahis M; Davis J; Wang R; Layton G; Choo HW; Chong CL; Tawadrous M
Antimicrob Agents Chemother; 2012 Aug; 56(8):4303-9. PubMed ID: 22644026
[TBL] [Abstract][Full Text] [Related]
9. Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis.
Ignatius EH; Abdelwahab MT; Hendricks B; Gupte N; Narunsky K; Wiesner L; Barnes G; Dawson R; Dooley KE; Denti P
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229425
[TBL] [Abstract][Full Text] [Related]
10. Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin.
Alnewais ME; Landolfa SL; Bean M; Fermo JD
J Prim Care Community Health; 2023; 14():21501319231197588. PubMed ID: 37750044
[TBL] [Abstract][Full Text] [Related]
11. Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Sheldon SH; Cunnane R; Lavu M; Parikh V; Atkins D; Reddy YM; Berenbom LD; Emert MP; Pimentel R; Dendi R; Lakkireddy DR
Pacing Clin Electrophysiol; 2018 Jul; 41(7):799-806. PubMed ID: 29659027
[TBL] [Abstract][Full Text] [Related]
12. Bleeding on the cutting edge: A systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery.
Isted A; Cooper L; Colville RJ
J Plast Reconstr Aesthet Surg; 2018 Apr; 71(4):455-467. PubMed ID: 29233507
[TBL] [Abstract][Full Text] [Related]
13. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
14. Difficulties in anticoagulation management during coadministration of warfarin and rifampin.
Lee CR; Thrasher KA
Pharmacotherapy; 2001 Oct; 21(10):1240-6. PubMed ID: 11601670
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-Analysis on the Efficacy and Safety of Direct Oral Anticoagulants in Patients with Peripheral Artery Disease.
Peppas S; Sagris M; Bikakis I; Giannopoulos S; Tzoumas A; Kokkinidis DG; Ahmed Z; Korosoglou G; Malgor EA; Malgor RD
Ann Vasc Surg; 2022 Mar; 80():1-11. PubMed ID: 34644644
[TBL] [Abstract][Full Text] [Related]
16. Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.
McCance-Katz EF; Moody DE; Prathikanti S; Friedland G; Rainey PM
Drug Alcohol Depend; 2011 Nov; 118(2-3):326-34. PubMed ID: 21596492
[TBL] [Abstract][Full Text] [Related]
17. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
Dhillon J; Mitchison DA
Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
[TBL] [Abstract][Full Text] [Related]
18. Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine.
Nakajima A; Fukami T; Kobayashi Y; Watanabe A; Nakajima M; Yokoi T
Biochem Pharmacol; 2011 Dec; 82(11):1747-56. PubMed ID: 21856291
[TBL] [Abstract][Full Text] [Related]
19. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
20. The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.
Smith K; Weeks S
JBI Libr Syst Rev; 2012; 10(58):4610-4621. PubMed ID: 27820526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
